Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0000898432-24-000401 0001745375 XXXXXXXX LIVE 5 Class A Common Stock, par value $0.01 03/14/2025 false 0001723128 03168L105 Amneal Pharmaceuticals, Inc. 400 Crossing Blvd Bridgewater NJ 08807 Edward Coss (949) 610-8022 520 Newport Center Drive 21th Floor Newport Beach CA 92660 0001745375 Patel Tushar Bhikhubhai a OO X1 48578209 0 48578209 0 48578209 N 15.7 IN The percentage of ownership of the Class A Common Stock by the Reporting Person presented in this Statement is based on 309,966,341 shares of Class A Common Stock outstanding as of February 14, 2025, as reported in the Issuer's Annual Report on Form 10-K filed on February 28, 2025. Class A Common Stock, par value $0.01 Amneal Pharmaceuticals, Inc. 400 Crossing Blvd Bridgewater NJ 08807 On March 14, 2025, the Reporting Person caused TI SIE 2, LLC, a Delaware limited liability company ("TI SIE 2"), the sole member of which is a trust controlled by the Reporting Person, to sell 5,000,000 shares of Class A Common Stock in a block trade to Citigroup Global Markets Inc., at a price per share of $8.35. The purpose of this transaction was to obtain liquidity for a portion of the shares of Class A Common Stock beneficially owned by the Reporting Person. The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by the Reporting Person, as well as the number of shares of Class A Common Stock as to which the Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition, as of the date hereof, based on 309,966,341 shares of Class A Common Stock outstanding as of February 14, 2025, as reported in the Issuer's Annual Report on Form 10-K filed on February 28, 2025: Reporting Person - Tushar Patel Amount Beneficially Owned - 48,578,209 Percent of Class - 15.7 Sole power to vote or to direct the vote - 48,578,209 Shared power to vote or to direct the vote - 0 Sole power to dispose or to direct the disposition - 48,578,209 Shared power to dispose or to direct the disposition - 0 The Reporting Person may be deemed to beneficially own 48,578,209 shares of Class A Common Stock held of record by TI SIE 2. The information set forth in Item 4 of this Amendment No. 5 is incorporated by reference herein. None. Not applicable. Patel Tushar Bhikhubhai Tushar Patel Patel Tushar Bhikhubhai 03/17/2025